Omnicell, Inc. OMCL
33.66
0.67
2.03%
as of 25 Sep
- Market cap
- $1.5B
- P/E
- 39.5×
Follow OMCL
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
1.62% | 0.17% | 1.63% | 3.06% | |
| 0.94% | 0.10% | 0.98% | 1.89% | ||
ROIC |
0.89% | 0.27% | 1.77% | 3.10% | |
Return on Tangible Assets |
6.17% | 0.63% | 5.66% | 9.53% | |
Average Days of Receivables |
76.15 | 66.80 | 74.43 | 66.47 | |
Free Cash Flow per Share |
2.06 | 1.51 | 2.16 | 2.78 | |
Free Cash Flow |
93.75 | 69.37 | 97.82 | 126.77 | |
Capital Expenditures |
(59.51) | (57.93) | (58.06) | (54.67) | |
Piotroski F-Score |
8.00 | 7.00 | 8.00 | 8.00 | |
| Other line items | |||||
Cash ROIC |
9.77% | 7.98% | 9.37% | 10.36% | |
Accounts Receivable Turnover |
4.73 | 5.01 | 4.89 | 5.42 | |
Accounts Payable Turnover |
12.02 | 14.23 | 12.40 | 12.27 | |
Inventory Turnover |
6.55 | 7.19 | 7.27 | 6.80 | |
Average Days of Payables |
34.41 | 23.56 | 30.77 | 26.39 | |
Days of Inventory on Hand |
59.16 | 54.05 | 52.31 | 51.27 | |
Tax Rate |
(0.42) | (0.82) | (0.46) | (0.36) | |
Research and Development Expense of Revenue |
7.83% | 7.48% | 7.32% | 7.09% | |
Selling, General and Administrative Expense of Revenue |
34.44% | 34.57% | 33.43% | 33.03% | |
Share Based Compensation of Revenue |
3.53% | 3.76% | 3.53% | 3.60% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
7.69 | 62.04 | 7.63 | 4.64 | |
Depreciation/Fixed assets |
0.75 | 0.74 | 0.72 | 0.71 | |
Capex/Depreciation |
(0.66) | (0.65) | (0.66) | (0.63) | |
Revenue per Share |
25.86 | 25.78 | 27.03 | 27.33 | |
Operating CF per Share |
3.37 | 2.77 | 3.44 | 3.98 | |
Capex per Share |
(1.31) | (1.26) | (1.28) | (1.20) | |
Capex to Sales |
0.05 | 0.05 | 0.05 | 0.04 | |
Net Profit Margin |
1.69% | 0.17% | 1.67% | 3.13% |
Columns are period end dates